Amgen Inc (AMGN) Dividend History

Amgen Inc. is a global biopharmaceutical company focused on developing and manufacturing innovative medicines in areas such as oncology, nephrology, and inflammation. Founded in 1980, Amgen is known for its work in biologic therapies and has a strong portfolio of blockbuster drugs aimed at improving patient lives.

One Amgen Center Drive, Thousand Oaks, CA, 91320
Phone: (805)447-1000
Website: https://www.amgen.com

Dividend Yield: 3.13%

Dividend Frequency: Quarterly

Dividend History

Pay Date	Amount	Ex Dividend Date	Record Date
September 12, 2025	$2.38	08/22/2025	08/22/2025
June 06, 2025	$2.38	05/16/2025	05/16/2025
March 07, 2025	$2.38	02/14/2025	02/14/2025
December 09, 2024	$2.25	11/18/2024	11/18/2024
September 06, 2024	$2.25	08/16/2024	08/16/2024
June 07, 2024	$2.25	05/16/2024	05/17/2024
March 07, 2024	$2.25	02/15/2024	02/16/2024
December 08, 2023	$2.13	11/16/2023	11/17/2023
September 08, 2023	$2.13	08/17/2023	08/18/2023
June 08, 2023	$2.13	05/17/2023	05/18/2023
March 08, 2023	$2.13	02/14/2023	02/15/2023
December 08, 2022	$1.94	11/16/2022	11/17/2022
September 08, 2022	$1.94	08/17/2022	08/18/2022
June 08, 2022	$1.94	05/16/2022	05/17/2022
March 08, 2022	$1.94	02/14/2022	02/15/2022
December 08, 2021	$1.76	11/15/2021	11/16/2021
September 08, 2021	$1.76	08/16/2021	08/17/2021
June 08, 2021	$1.76	05/14/2021	05/17/2021
March 08, 2021	$1.76	02/11/2021	02/15/2021
December 08, 2020	$1.60	11/13/2020	11/16/2020
September 08, 2020	$1.60	08/14/2020	08/17/2020
June 08, 2020	$1.60	05/15/2020	05/18/2020
March 06, 2020	$1.60	02/13/2020	02/14/2020
December 06, 2019	$1.45	11/14/2019	11/15/2019
September 06, 2019	$1.45	08/14/2019	08/15/2019
June 07, 2019	$1.45	05/16/2019	05/17/2019
March 08, 2019	$1.45	02/14/2019	02/15/2019
December 07, 2018	$1.32	11/15/2018	11/16/2018
September 07, 2018	$1.32	08/16/2018	08/17/2018
June 08, 2018	$1.32	05/16/2018	05/17/2018
March 08, 2018	$1.32	02/14/2018	02/15/2018
December 08, 2017	$1.15	11/16/2017	11/17/2017
September 08, 2017	$1.15	08/15/2017	08/17/2017
June 08, 2017	$1.15	05/15/2017	05/17/2017
March 08, 2017	$1.15	02/13/2017	02/15/2017
December 08, 2016	$1.00	11/14/2016	11/16/2016
September 08, 2016	$1.00	08/15/2016	08/17/2016
June 08, 2016	$1.00	05/13/2016	05/17/2016
March 08, 2016	$1.00	02/11/2016	02/16/2016
December 07, 2015	$0.79	11/12/2015	11/16/2015
September 08, 2015	$0.79	08/13/2015	08/17/2015
June 05, 2015	$0.79	05/12/2015	05/14/2015
March 06, 2015	$0.79	02/10/2015	02/12/2015
December 05, 2014	$0.61	11/10/2014	11/13/2014
September 05, 2014	$0.61	08/12/2014	08/14/2014
June 06, 2014	$0.61	05/13/2014	05/15/2014
March 07, 2014	$0.61	02/11/2014	02/13/2014
December 06, 2013	$0.47	11/12/2013	11/14/2013
September 06, 2013	$0.47	08/14/2013	08/16/2013
June 07, 2013	$0.47	05/14/2013	05/16/2013
March 07, 2013	$0.47	02/11/2013	02/13/2013
December 07, 2012	$0.36	11/13/2012	11/15/2012
September 07, 2012	$0.36	08/14/2012	08/16/2012
June 07, 2012	$0.36	05/14/2012	05/16/2012
March 07, 2012	$0.36	02/13/2012	02/15/2012
December 08, 2011	$0.28	11/15/2011	11/17/2011
September 08, 2011	$0.28	08/16/2011	08/18/2011

Dividends Summary

Amgen Inc has issued 57 dividend payments over the past 14 years
The most recent dividend was paid 75 days ago, on June 6, 2025
The first recorded dividend was paid on September 8, 2011
The highest dividend payout was $2.38 per share
The average dividend over this 14 year span is $1.32 per share
Amgen Inc has increased its dividend payments by 750.00% since 2011

Company News

Ligand to Participate in September Investor Conferences

Ligand Pharmaceuticals executives will participate in two upcoming investor conferences: Citi 20th Annual BioPharma Conference in Boston and H.C. Wainwright 27th Annual Global Investment Conference in New York, presenting and hosting investor meetings.

GlobeNewswire Inc.

Featured Companies: BAX GILD JAZZ LGND MRK PFE
CytomX (CTMX) Q2 Revenue Drops 26%

CytomX Therapeutics reported Q2 2025 results with declining revenue, reduced operating expenses, and positive clinical pipeline progress, particularly for its lead colorectal cancer candidate CX-2051.

The Motley Fool

Featured Companies: BMY CTMX MRNA
Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators

Pharmaceutical companies are advancing treatments for rare diseases, with Soligenix leading efforts in developing HyBryte, a promising therapy for cutaneous T-cell lymphoma (CTCL), a rare skin cancer affecting older adults.

Benzinga

Featured Companies: CTOR FOLD SNGX TNXP
Will Defensive Sectors Keep Driving Dow’s Outperformance This Summer?

The Dow Jones Industrial Average is outperforming other indices due to a shift towards defensive sectors, driven by economic uncertainty and potential Federal Reserve rate cuts. Healthcare and pharmaceutical stocks are leading the gains.

Investing.com

Page data last updated 08/20/2025 00:46:24 UTC Dividend yield is calculated using only dividends that have already been paid. Future or declared dividends are not included

Amgen Inc (AMGN) Dividend History

Dividend History

Dividends Summary

Company News

Related Companies